RGD-Coated Polymer Nanoworms for Enriching Cancer Stem Cells
Open Access
Abstract
Cancer stem cells (CSCs) are primarily responsible for tumour drug resistance and metastasis; thus, targeting CSCs can be a promising approach to stop cancer recurrence. However, CSCs are small in numbers and readily differentiate into matured cancer cells, making the study of their biological features, including therapeutic targets, difficult. The use of three-dimensional (3D) culture systems to enrich CSCs has some limitations, including low sphere forming efficiency, enzymatic digestion that may damage surface proteins, and more importantly no means to sustain the stem properties. A responsive 3D polymer extracellular matrix (ECM) system coated with RGD was used to enrich CSCs, sustain stemness and avoid enzymatic dissociation. RGD was used as a targeting motif and a ligand to bind integrin receptors. We found that the system was able to increase sphere forming efficiency, promote the growth of spheric cells, and maintain stemness-associated properties compared to the current 3D culture. We showed that continuous culture for three generations of colon tumour spheroid led to the stem marker CD24 gradually increasing. Furthermore, the new system could enhance the cancer cell sphere forming ability for the difficult triple negative breast cancer cells, MBA-MD-231. The key stem gene expression for colon cancer also increased with the new system. Further studies indicated that the concentration of RGD, especially at high doses, could inhibit stemness. Taken together, our data demonstrate that our RGD-based ECM system can facilitate the enrichment of CSCs and now allow for the investigation of new therapeutic approaches for colorectal cancer or other cancers.Keywords
Funding Information
- Australia Research Council Discovery Project (DP190103073)
This publication has 52 references indexed in Scilit:
- Reversible polymer nanostructures by regulating SDS/PNIPAM bindingPolymer Chemistry, 2012
- Silencing oncogene expression in cervical cancer stem-like cells inhibits their cell growth and self-renewal abilityCancer Gene Therapy, 2011
- Evidence for label-retaining tumour-initiating cells in human glioblastomaBrain, 2011
- CD44posCD49fhiCD133/2hi Defines Xenograft-Initiating Cells in Estrogen Receptor–Negative Breast CancerCancer Research, 2010
- Integrins in cancer: biological implications and therapeutic opportunitiesNature Reviews Cancer, 2010
- Identification of Vitronectin as an Extrinsic Inducer of Cancer Stem Cell Differentiation and Tumor FormationStem Cells, 2009
- let-7 Regulates Self Renewal and Tumorigenicity of Breast Cancer CellsCell, 2007
- Identification and expansion of the tumorigenic lung cancer stem cell populationCell Death & Differentiation, 2007
- The NCI60 human tumour cell line anticancer drug screenNature Reviews Cancer, 2006
- In vitro propagation and transcriptional profiling of human mammary stem/progenitor cellsGenes & Development, 2003